Business Description
Novavax Inc
NAICS : 325414
SIC : 2836
ISIN : US6700024010
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.1 | |||||
Equity-to-Asset | -0.64 | |||||
Debt-to-Equity | -0.26 | |||||
Debt-to-EBITDA | -0.68 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -4.94 | |||||
Beneish M-Score | -3.45 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 142.1 | |||||
3-Year EBITDA Growth Rate | 11.2 | |||||
3-Year EPS without NRI Growth Rate | 9.4 | |||||
3-Year FCF Growth Rate | -65.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 37.9 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.7 | |||||
9-Day RSI | 76.5 | |||||
14-Day RSI | 77.83 | |||||
6-1 Month Momentum % | -23 | |||||
12-1 Month Momentum % | -46.15 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.9 | |||||
Quick Ratio | 0.88 | |||||
Cash Ratio | 0.6 | |||||
Days Inventory | 36.56 | |||||
Days Sales Outstanding | 87.37 | |||||
Days Payable | 99.8 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.3 | |||||
Shareholder Yield % | -7.93 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 53.53 | |||||
Operating Margin % | -50.21 | |||||
Net Margin % | -50.23 | |||||
FCF Margin % | -64.72 | |||||
ROA % | -24.81 | |||||
ROIC % | -24.81 | |||||
ROC (Joel Greenblatt) % | -84.3 | |||||
ROCE % | -311.23 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.18 | |||||
EV-to-EBIT | -5.15 | |||||
EV-to-EBITDA | -5.82 | |||||
EV-to-Revenue | 2.47 | |||||
EV-to-Forward-Revenue | 2.12 | |||||
EV-to-FCF | -3.88 | |||||
Price-to-Median-PS-Value | 0.11 | |||||
Earnings Yield (Greenblatt) % | -19.43 | |||||
FCF Yield % | -23.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Novavax Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 13,629.752 | ||
EPS (TTM) (MXN) | -54.687 | ||
Beta | -0.58 | ||
Volatility % | 40.38 | ||
14-Day RSI | 77.83 | ||
14-Day ATR (MXN) | 17.7794 | ||
20-Day SMA (MXN) | 206.2945 | ||
12-1 Month Momentum % | -46.15 | ||
52-Week Range (MXN) | 65.1 - 285 | ||
Shares Outstanding (Mil) | 147.3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Novavax Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Novavax Inc Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Novavax Inc Frequently Asked Questions
What is Novavax Inc(MEX:NVAX)'s stock price today?
When is next earnings date of Novavax Inc(MEX:NVAX)?
Does Novavax Inc(MEX:NVAX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |